Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds

More articles from Radionuclide Therapy

  • Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu Prostate-Specific Membrane Antigen
    You have access
    Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu Prostate-Specific Membrane Antigen
    Yung Hsiang Kao
    Journal of Nuclear Medicine Technology May 9, 2025, jnmt.125.269658; DOI: https://doi.org/10.2967/jnmt.125.269658
  • You have access
    Survey of Clinical Protocols for the Use of 177Lu-PSMA-617 in the United States
    Phillip H. Kuo, Matthew F. Covington, Daniel J. Lee, Terence Z. Wong and Neeta Pandit-Taskar
    Journal of Nuclear Medicine Technology September 1, 2024, 52 (3) 208-211; DOI: https://doi.org/10.2967/jnmt.123.266769
  • First-Strike Rapid Predictive Dosimetry and Dose Response for <sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    You have access
    First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Yung Hsiang Kao, Nadia Falzone, Michael Pearson and Dinesh Sivaratnam
    Journal of Nuclear Medicine Technology September 1, 2024, 52 (3) 212-218; DOI: https://doi.org/10.2967/jnmt.123.267067
  • The Effect of <sup>131</sup>I Therapy on the Eradication of <em>Helicobacter pylori</em> in Patients with Thyroid Disorders: A Preliminary Study
    You have access
    The Effect of 131I Therapy on the Eradication of Helicobacter pylori in Patients with Thyroid Disorders: A Preliminary Study
    Farhad Pourfarzi, Hossein Pakrouy, Ali Mohammadian Erdi and Elnaz Faghfuri
    Journal of Nuclear Medicine Technology June 1, 2024, 52 (2) 144-147; DOI: https://doi.org/10.2967/jnmt.123.266508
  • Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    You have access
    Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    Caio Vinicius Oliveira, Tatiane Sabriela Cagol Camozzato, Patricia Fernanda Dorow and Jéssica Pasqueta
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 233-239; DOI: https://doi.org/10.2967/jnmt.121.263502
  • You have access
    Review of Palliative 223Ra in Metastatic Castration-Resistant Prostate Cancer: Experience at West Virginia University Cancer Center
    Ruta Arays, Zeeshan Ahmad, Lorinda Howard, Kenneth Veselicky, Joanna Kolodney, SijinWen and Thomas Hogan
    Journal of Nuclear Medicine Technology March 1, 2021, 49 (1) 70-74; DOI: https://doi.org/10.2967/jnmt.120.254474
  • You have access
    Analysis of Radiometry on Patients Undergoing Radioactive Iodine Therapy
    Pietro Paolo de Barros, Tatiane Sabriela Cagol Camozzato, Tiago Jahn, Flávio Augusto Penna Soares, Letícia Machado da Silva, Jacqueline de Aguiar Soares and Marco Antonio Neiva Koslosky
    Journal of Nuclear Medicine Technology March 1, 2021, 49 (1) 75-81; DOI: https://doi.org/10.2967/jnmt.120.246512
  • You have access
    177Lu-EDTMP for Treatment of Bone Pain in Patients with Disseminated Skeletal Metastases
    Ajit S. Shinto, Deepu Shibu, Koramadai Karuppusamy Kamaleshwaran, Tapas Das, Sudipta Chakraborty, Sharmila Banerjee, Palanisamy Thirumalaisamy, Pravin Das and Ganesh Veersekar
    Journal of Nuclear Medicine Technology March 1, 2014, 42 (1) 55-61; DOI: https://doi.org/10.2967/jnmt.113.132266
SNMMI

© 2025 SNMMI

Powered by HighWire